09.17.25 -- How To Hire And Build A Winning Executive Team

Navigating France’s Early Access Program is more complex than ever. Amid declining approval rates and mandatory data collection, learn what pharmaceutical companies need to know about the changing landscape.

Breakthroughs in regenerative medicine are transforming healthcare in Winston-Salem, where experts are developing therapies to help the body heal itself—repairing tissue and even regenerating organs.

This piece explores intentional culture-building as a strategic asset in Functional Service Provider (FSP) engagements, transforming transactional relationships into enduring, high-performing partnerships.

Discover how one family defied the odds—bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.

As demand forecasts evolve, opt to work with a CDMO that can pivot manufacturing strategies seamlessly while accommodating your end-to-end needs, from drug substance to finished goods.

Examine the complexities of participant payments with a focus on prepaid cards and other payment methods. Delve into the importance of catering to participant preferences and outlining payment options.

See how a leading biopharma company boosted flexibility and quadrupled productivity by implementing a concentrated fed-batch process in a single-use facility.